Clinical trial
An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death
NCT06604169 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 1, 2024
- Completion date
- July 31, 2028
- Enrollment
- 589 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hcm - hypertrophic cardiomyopathy, s-icd system (implantable defibrillator)